Divergent Roles of MASLD Components in Chronic Hepatitis B: A Double-Edged Sword

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2025-02-28 DOI:10.1016/j.jhep.2025.02.035

Shang-Chin Huang, Tung-Hung Su

{"title":"Divergent Roles of MASLD Components in Chronic Hepatitis B: A Double-Edged Sword","authors":"Shang-Chin Huang, Tung-Hung Su","doi":"10.1016/j.jhep.2025.02.035","DOIUrl":null,"url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Authors' contributions</h2>SC Huang: study concept and design; drafting of the manuscript; obtaining fundingTH Su: study concept and design; critical revision for important intellectual content; obtaining funding</section></section><section><section><h2>Declaration of AI-assisted technologies in the writing process</h2>During the preparation of this work, the authors used Grammarly for English proofreading and editing. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.</section></section><section><section><h2>Financial support</h2>This work was supported by grants from the National Science and Technology Council, Taiwan (grant number NSTC 112-2628-B-002-004, 112-2314-B-002-121-MY3), Ministry of Health and Welfare (MOHW113-TDU-B-221-134003), National Taiwan University Hospital (grant numbers VN-113-04, 113-TMU09, 113-S0156, 113-L3004, 113-L3005), and National Taiwan University Hospital Bei-Hu Branch, Taiwan (grant number 11308).</section></section><section><section><h2>Declaration of Competing Interest</h2>S.-C. H. was on speaker’s bureau for Gilead Sciences.T.-H. S. received a research grant from Gilead Sciences, served as a consultant for Gilead Sciences, and was on speaker’s bureaus for Abbvie, Bayer, Bristol-Myers Squibb, Gilead Sciences, Lilly, Merck Sharp and Dohme, Roche, Sysmex and Takeda.Please refer to the accompanying ICMJE disclosure forms for further details.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"32 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhep.2025.02.035","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Section snippets

Authors' contributions

SC Huang: study concept and design; drafting of the manuscript; obtaining fundingTH Su: study concept and design; critical revision for important intellectual content; obtaining funding

Declaration of AI-assisted technologies in the writing process

During the preparation of this work, the authors used Grammarly for English proofreading and editing. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.

Financial support

This work was supported by grants from the National Science and Technology Council, Taiwan (grant number NSTC 112-2628-B-002-004, 112-2314-B-002-121-MY3), Ministry of Health and Welfare (MOHW113-TDU-B-221-134003), National Taiwan University Hospital (grant numbers VN-113-04, 113-TMU09, 113-S0156, 113-L3004, 113-L3005), and National Taiwan University Hospital Bei-Hu Branch, Taiwan (grant number 11308).

Declaration of Competing Interest

S.-C. H. was on speaker’s bureau for Gilead Sciences.T.-H. S. received a research grant from Gilead Sciences, served as a consultant for Gilead Sciences, and was on speaker’s bureaus for Abbvie, Bayer, Bristol-Myers Squibb, Gilead Sciences, Lilly, Merck Sharp and Dohme, Roche, Sysmex and Takeda.Please refer to the accompanying ICMJE disclosure forms for further details.

查看原文本刊更多论文

MASLD成分在慢性乙型肝炎中的不同作用：一把双刃剑

黄晓明：研究理念与设计；撰写稿件；th苏：研究理念与设计；对重要知识内容的批判性修改；在准备工作中，作者使用Grammarly进行英语校对和编辑。使用此工具后，作者根据需要审查和编辑内容，并对出版物的内容负全部责任。竞争利益声明。H.是吉利德科学公司的发言人。获得Gilead Sciences的研究资助，担任Gilead Sciences的顾问，并在Abbvie、Bayer、Bristol-Myers Squibb、Gilead Sciences、Lilly、Merck Sharp和Dohme、Roche、Sysmex和Takeda的演讲局任职。详情请参阅随附的ICMJE披露表格。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.